Share on Google Plus Share on Twitter 1 Share on Facebook 1 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend 2 (4 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   3 comments
General News

Now Praised, Six Years Ago Aspirin Was Denigrated by Vioxx Marketing

By       Message Martha Rosenberg     Permalink
      (Page 1 of 2 pages)
Related Topic(s): ; ; ; ; ; ; ; ; , Add Tags Add to My Group(s)

Must Read 2   Well Said 2   Supported 1  
View Ratings | Rate It

opednews.com Headlined to H4 12/9/10

Author 1353
Become a Fan
  (79 fans)

 It has only been six years since the COX-2 specific inhibitor Vioxx was billed as a super aspirin that didn't have aspirin's "risks" by Merck. Widely advertised and pitched by Olympians Dorothy Hamill and Bruce Jenner, Vioxx turned out to double the risk of heart attack and was withdrawn from the market in 2004.

 

27,785 patients suffered heart attacks and sudden cardiac deaths on Vioxx, according to the FDA. Merck was also accused of concealing "critical data on an array of adverse cardiovascular events," by the New England Journal of Medicine.


Pharma reps discuss aspirin news
(Image by Martha Rosenberg)
  Permission   Details   DMCA

 

Bextra, a COX-2 specific inhibitor similar to Vioxx, was also withdrawn for similar reasons in 2005. In fact, patients taking Bextra after heart surgery were 2.19 times more likely to suffer a stroke or heart attack according to American Heart Association information. And last year Pfizer agreed to pay $2.3 billion for fraudulent marketing of Bextra and three other drugs. Not million, billion.

 

This week a meta-analysis in Lancet, the British medical weekly, reveals that common aspirin may reduce the chances of dying of several cancers. People who took a daily aspirin for more than four years reduced their chances of dying of cancer by 21 percent according to the data published this week. And, the longer they took the aspirin -- up to twenty years -- the greater their cancer risk reduction, said researchers.

 

Many Americans over 45 already take a daily, low-dose aspirin to protect against cardiovascular events and stroke.

 

While aspirin's ability to lower colon cancer risk was known, esophageal, gastrointestinal, lung, brain, and pancreatic cancers dropped in the population of patients taking daily aspirin said researchers.

 

The trials were conducted to explore the vascular effects of a daily aspirin on patients but the authors found the risk of esophageal and throat cancer was reduced by 60 percent, colorectal cancer by 40 percent, lung cancer by 30 percent and prostate cancer by 10 percent.

 

Next Page  1  |  2

 

- Advertisement -

Must Read 2   Well Said 2   Supported 1  
View Ratings | Rate It

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon



Go To Commenting
/* The Petition Site */
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too